Call for Papers

Our Focus Issues are designed to provide a concentrated collection of articles on specific topics of interest to the scientific community and promote in-depth exploration and discussion within these areas. The Journal of Pathology, Microbiology and Immunology welcomes submissions within the scope of each individual call.

This page is dedicated to our current Calls for Papers and is getting updated continuously.

  • Journal of Pathology, Microbiology and Immunology – 100 Years Centennial Focus Issue
    Special editors: Thomas Bjarnsholt, Louise Kruse Jensen, Peter Østrup Jensen & Ulrik Ralfkiær
    Deadline for submissions: 1 June 2024
  • Focus Issue: The microenvironment in human disease
    Special editors: Peter Østrup Jensen & Mads Lichtenberg
    1 February 2024

The Microenvironment in Human Disease

The Journal of Pathology, Microbiology and Immunology is welcoming submissions related to the microenvironment in human disease to be presented in our Focus Issue 2024. We encourage submissions that link the importance of the microenvironment to human disease by investigating the distribution of cells and molecules in the tumor microenvironment, the immune microenvironment, or the infectious microenvironment. In addition, we appreciate examinations of the microenvironment in drug testing and cultivation of human cells, tissues, and organs to be transplanted for therapeutic purposes.

This special issue will comprise original articles, reviews, and short communications that highlight recent advances in relating the microenvironment in human disease to therapeutic potentials and diagnosis. Articles will be invited from prominent researchers in these fields, but spontaneous submissions are also welcome. All the submitted manuscripts will be subjected to independent peer review and those of low priority will be rejected. There are no costs for publishing with APMIS and all accepted manuscripts for this focus issue will be published as free access.

Topics for this call for papers include but not restricted to:

  • Microenvironmental determinators of pathogens susceptibility to antimicrobials
  • Microenvironmental determinators of the ability of pathogens to persist
  • Targeting the infectious microenvironment for optimized treatment
  • Targeting tumor microenvironment for cancer therapy
  • Identification of the molecular and cellular drivers of cancer immunity
  • Development of pre-clinical models that translate to human immunity
  • Manipulating the microenvironment to improve treatment
  • The applications of CRISPR-Cas9 in cancer immunotherapy.